Basic knowledge of ovarian cancer pathology

Disease Overview

Tags: age, breast, cancer, carcinoma, cause, cell, cells, chemotherapy, children, diagnosis, early, eat, ert, fat, gene, group, incidence, increased, knowledge, life, lymph, malignant, metastatic, ovarian, patients, preventive, radiotherapy, rate, risk, second, surface, surgery, survival, symptoms, tea, therapy, time, treatment, tumor, tumors, uterine, women

Ovarian cancer care

One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.

One, information and Methods

Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, women

Interferon combined with the chemotherapy treatment of ovarian cancer

Austria adopted interferon combination of chemotherapy and women's ovarian cancer treatment, and achieved better than chemotherapy alone effect.

Austrian University of Innsbruck gynecological experts led by Professor Christian Anmaerte a Gynecologic Oncology Group study started three years ago one of the study. Their 148 already one ovarian cancer surgery in women with a combination of chemotherapy for the treatment of interferon test. Six patients received treatment three times a week in treatment, and the other a comparison group of patients is only chemotherapy. Results of 51% in patients treated with interferon did not recur tumor, and comparison group only 38% of patients with tumors did not recur.

Tags: blood, body, cancer, cell, cells, chemotherapy, eat, ert, group, growth, gynecological, interferon, ovarian, patients, protein, study, surgery, therapy, time, treatment, tumor, tumors, women

Hormone replacement therapy and gynecologic malignancies relations

I. Overview

With the aging of the global trend of development, improve the economic status of women, more and more women start hormone replacement therapy (Hormone Replacement Therapy, HRT), to improve access to after menopause due to the decrease in the level of sex hormones related to various diseases. Clear evidence that: postmenopausal women with age, the incidence of coronary heart disease increased by about four times the fracture due to osteoporosis by 20%, died of complications due to pelvic fracture rate of 30%, after the 65-year-old Alzheimer's incidence rate increase every year <BR> and Application HRT can peer groups coronary heart disease risk 50% Alzheimer's risk reduced three times, especially worth mentioning is significantly reduced the incidence of rectal cancer. Long-term use of HRT cancer risk reduced year by year. HRT can also greatly improve the menopause, postmenopausal women with disease or ovarian surgery, radiotherapy in patients with a series of artificial menopause syndrome.

Tags: age, benign, blood, body, brca1, breast, cancer, carcinoma, care, cases, cause, cell, cells, clinical, cyst, cystic, diagnosis, diet, drug, early, eat, ert, estrogen, family, fat, gene, grams, group, groups, growth, gynecological, history, hrt, incidence, increased, injection, intravenous, life, lymph, malignant, metastasis, method, mutation, node, ovarian, patients, pelvic, positive, protein, quality, radiotherapy, rate, reduce, residual, risk, screening, second, study, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, tumors, usually, uterine, women

Cytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects

Cytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects

Foreign Medical Obstetrics and Gynecology volumes in 1999 Vol 26 No. 2

Tianjin Medical University General Hospital of Obstetrics and Gynecology (300,052) of the new QU (Summary) if Mi (revision)

Abstract <BR> since the 1980s, complete cytoreductive surgery to cisplatin-based combination chemotherapy for ovarian cancer as a conventional model, cytoreductive surgery is the complete impact of the prognosis of patients with one of the important factors for recurrent ovarian cancer once again cytoreductive surgery still some value , but to improve the survival rate of patients is more important to be effective after chemotherapy treatment as a necessary complement. Early ovarian cancer retroperitoneal lymph node dissection is reasonable and significance of the still controversial.

Tags: abdominal, age, annex, anti, bleeding, blood, cancer, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, early, eat, ert, exploration, gene, growth, incidence, increased, intraperitoneal, intravenous, life, lymph, malignant, metastasis, metastatic, method, mutation, node, ovarian, p53, patients, pelvic, physical, poor, positive, prognosis, quality, rate, reduce, resection, residual, response, second, staging, study, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors

Ovarian Cancer Diagnosis

Diagnosis
Not obvious early symptoms of ovarian cancer, so early diagnosis depends on the regular census.

1. Past history should be asked whether particular pelvic mass or the recent history of tumor growth. Women over 40 years of age and unexplained gastrointestinal symptoms, and should be gynecological examinations.
2. Body check, can be found abdominal mass, ascites positive sign.
3. Gynecological examinations beside mass, although it is solid or cystic, irregular activities of the poor, and often bilateral. Triple consultation found dome nodule or mass.
4. Auxiliary

Tags: abdominal, age, anti, benign, body, cancer, carcinoma, cell, cells, cyst, cystic, diagnosis, early, examination, growth, gynecological, history, increased, malignant, mass, ovarian, pelvic, poor, positive, protein, symptoms, tumor, women

Mesenchymal cells of the ovary

Mesenchymal cells of the ovary (Loydig cell tumor):

(1) of the cell door: This tumor is rare. As a <BR> ovarian portal that since the tumor cell door. More common in women after menopause, the main clinical manifestations of masculine symptoms, but sometimes there will be high performance estrogen, and with endometrial hyperplasia, endometrial cancer.

[Giant seizure] often unilateral, bilateral and occasionally simultaneously ovarian tumor. Tumor sizes. In ovarian portal, but the majority of ovarian tumors can be occupied. Tumor section for substantive, yellow or brownish yellow, with cystic degeneration and bleeding.

Tags: anti, bleeding, cancer, cell, cells, clinical, cyst, cystic, estrogen, gene, ovarian, ovary, symptoms, time, tumor, tumors, women

The classification of ovarian cyst

Many primary ovarian cyst classification, as many as several dozen species, from different parts of ovarian, divided into four broad categories:

(1) epithelial tumors,
Most see is a, as serous cystadenoma (cancer), mucinous cystadenoma (cancer).

(2) reproductive cells derived from germ cell tumor.
Common teratoma (also known as dermoid cyst), includes skin, teeth, bones, side by side focus, often in torsion.

(3) gonadal stromal cell tumors, granulosa cell tumor of the common, theca cell tumor, the result of the secret function, also known as functional ovarian tumor. Above all primary malignant tumor which is.

Tags: benign, cancer, cell, cells, cyst, cystic, lymph, malignant, ovarian, skin, tumor, tumors

Experts of ovarian cancer

Ovarian cancer
Tags: abdominal, age, body, cancer, cause, cell, cells, chemotherapy, clinical, days, early, eat, ert, examination, family, gene, grams, gynecological, life, ovarian, patients, pelvic, poor, quality, radiotherapy, surgery, surgical, survival, symptoms, therapy, treatment, tumor, women

Uterine fibroids, ovarian cysts latest therapy

The researchers are aware, thoroughly treatment of uterine fibroids and ovarian cysts, breast lumps on the need to completely wipe out "derivative yuan Presents" and started to look for such drugs, "Xiao Rong in the film" get this problem solved. "Xiao Rong in the film" treatment of uterine fibroids and ovarian cysts, breast lumps divided into two steps.

First step: Xiao Rong in the first film screen blood infiltration technology, unique "crystal oxygen segregation" was targeted identification of blood plasma state slot, strong penetration of high density "blood barrier," sever all "derivative yuan Presents" oxygen supply guide "derivative yuan Presents" among phagocytic cells , forcing "derivative yuan Presents" overall contraction, layers and disintegrate, thus achieving a comprehensive system of female physiological turnaround.

Tags: blood, breast, cell, cells, cyst, cysts, drug, drugs, eat, ovarian, rate, second, therapy, treatment, uterine